AXX-33299-01473
5 vaccinations
1 coded response
35 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 275 / NC
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2021-01-06
Registered in v-safe
- 2021-01-06
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Chills, Muscle or body achesAdult check-in
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-04-08
- 2021-07-11
-
2021-08-27
Dose 3 — Pfizer-BioNTech
- 2021-09-28
- 2021-10-03
- 2021-10-08
- 2021-11-26
- 2022-02-27
-
2022-03-25
Dose 4 — Pfizer-BioNTechCo-administered: HPV
- 2022-08-27
-
2022-10-05
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-05
- 2022-10-06
- 2022-10-08
- 2022-10-09
- 2022-10-11
- 2022-10-13
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-11-16
-
2023-01-04
Survey response — 3 months, dose 5MedDRA: COVID-19, Cough, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-01-04
Report sent to call center — 3 months, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2023-01-05
Call successfulCompleted over the phone
- 2023-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-08-27 | Pfizer-BioNTech | No |
| 4 | 2022-03-25 | Pfizer-BioNTech | HPV |
| 5 | 2022-10-05 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release